Startup · $7m raised
Brisbane, QLD
Every investor coverage indicates participated in a round Eclipse Ingredients raised.
| Investor | Rounds | Invested |
|---|---|---|
| AgFunder | Unnamed stage | - |
| Commonwealth | Unnamed stage | $2,900,000 |
| Food and Beverage Accelerator (FaBA) | Unnamed stage | $2,900,000 |
Companies Eclipse Ingredients acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Eclipse Ingredients. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Interview with Eclipse Ingredients' chief executive on commercialising human lactoferrin through precision fermentation, beginning with cosmetics, plus its distributor agreements and partnerships for manufacturing scale-up.
Australian food-tech firm All G has launched a low-iron, fermentation-derived lactoferrin in the US, producing multiple tonnes yearly via a Chinese manufacturer, with European capacity and a human-equivalent version planned.
Weekly roundup detailing five Australian startups' raises: a PR platform's Series B, a biotech's post-stealth funding, a defence tech round, a pre-seed voice-AI raise, and a crowdfunding campaign.
Also Startup Daily
Precision fermentation startup Eclipse Ingredients has come out of stealth with a $7 million round backed by the Australian government and AgFunder to produce human lactoferrin for food and skincare markets.